Showing 7971-7980 of 21408 results for "".
- Phone App Uses AI to Detect Depression from Facial Cueshttps://reachmd.com/news/phone-app-uses-ai-to-detect-depression-from-facial-cues/2457326/Dartmouth researchers report they have developed the first smartphone application that uses artificial intelligence paired with facial-image processing software to reliably detect the onset of depression before the user even knows something is wrong.Called MoodCapture, the app us
- New Brain Stimulation Technique Shows Promise for Treating Brain Disordershttps://reachmd.com/news/new-brain-stimulation-technique-shows-promise-for-treating-brain-disorders/2457296/This figure summarizes the outcomes following ultrasound stimulation. Low-intensity brainwave-like pattern ultrasound stimulation sequentially stimulates TRPA1 in astrocytes, leading to B
- Patient Mindset Training Helps Care Teamshttps://reachmd.com/news/patient-mindset-training-helps-care-teams/2457305/Researchers Alia Crum and Kari Leibowitz facilitating a follow-up session to evaluate the outcomes of the “Medicine Plus Mindset” training. (Image credit
- Almodóvar Receives NIH Grant to Study Pulmonary Hypertension in HIV Patientshttps://reachmd.com/news/almodovar-receives-nih-grant-to-study-pulmonary-hypertension-in-hiv-patients/2457300/Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year. The majority of those afflicted — approximately 76% — have access to antiviral therapy that
- Benralizumab Proven Effective for Rare Vasculitis Treatmenthttps://reachmd.com/news/benralizumab-proven-effective-for-rare-vasculitis-treatment/2457297/Researchers have shown that the drug benralizumab is as effective and safe as mepolizumab for inducing remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) according to a study published today in The New England Journal of Medicine. The results of the non
- SK Bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccinehttps://reachmd.com/news/sk-bioscience-receives-who-prequalification-for-typhoid-conjugate-vaccine/2457299/SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced today that the company has obtained prequalification (PQ) certification from the World Health Organization (WHO) for its typhoid conjugate
- Do's and Dont's Developed for Direct Oral Anticoagulantshttps://reachmd.com/news/dos-and-donts-developed-for-direct-oral-anticoagulants/2457301/Central Illustration. Credit: Journal of the American College of Cardiology (2024). DOI: 10.1016/j.jacc.2023.10.038 D
- Yale Receives Grant to Fund Long COVID Researchhttps://reachmd.com/news/yale-receives-grant-to-fund-long-covid-research/2457308/The PolyBio Research Foundation awarded the Yale School of Medicine and its Center for Infection & Immunity (CII) a $575,000 grant to fund Long COVID Research. The grant will support a coll
- Fear of Cancer Recurrence Elevated Among Survivors of Localized Cutaneous Melanoma: Analysishttps://reachmd.com/news/lived-experiences-and-fear-of-cancer-recurrence-among-survivors-of-localized-cutaneous-melanoma/2462249/Patients who suffer from localized cutaneous melanoma report high levels of fear of cancer recurrence, according to a new analysis. Researchers investigating the psychological well-being and fear of cancer recurrence among survivors of localized cutaneous melanoma in the United States ev
- RAPT Faces 'Unfortunate and Unexpected' Clinical Hold After Liver Failure in Atopic Dermatitis Trialhttps://reachmd.com/news/rapt-faces-unfortunate-and-unexpected-clinical-hold-after-liver-failure-in-atopic-dermatitis-trial/2457286/Rapt Therapeutics is reeling from an “unfortunate and unexpected” clinical hold after a patient in a phase 2 immunology trial experienced liver failure that may be related to the study drug. That’s how CEO Brian Wong, M.D., Ph.D., described the turn of events in Tuesday’s